X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22417) 22417
Book Review (2924) 2924
Publication (810) 810
Book Chapter (193) 193
Conference Proceeding (105) 105
Magazine Article (62) 62
Dissertation (35) 35
Book / eBook (7) 7
Newspaper Article (5) 5
Web Resource (4) 4
Data Set (3) 3
Streaming Video (3) 3
Government Document (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17878) 17878
humans (13626) 13626
male (10239) 10239
female (8091) 8091
levodopa (8008) 8008
parkinson disease - drug therapy (7377) 7377
levodopa - therapeutic use (7045) 7045
parkinson's disease (7004) 7004
clinical neurology (6297) 6297
middle aged (6280) 6280
animals (5837) 5837
aged (5656) 5656
neurosciences (4972) 4972
levodopa - pharmacology (3959) 3959
antiparkinson agents - therapeutic use (3545) 3545
adult (3337) 3337
levodopa - adverse effects (3263) 3263
rats (3075) 3075
parkinson disease - physiopathology (2788) 2788
dopamine (2715) 2715
levodopa - administration & dosage (2651) 2651
l-dopa (2550) 2550
pharmacology & pharmacy (2225) 2225
parkinsons-disease (2173) 2173
antiparkinson agents - adverse effects (2007) 2007
abridged index medicus (1969) 1969
dopa (1937) 1937
dopamine - metabolism (1687) 1687
parkinson disease - complications (1588) 1588
neurology (1573) 1573
time factors (1508) 1508
basal ganglia (1472) 1472
dose-response relationship, drug (1468) 1468
drug therapy, combination (1445) 1445
parkinsons disease (1380) 1380
treatment outcome (1353) 1353
movement disorders (1333) 1333
antiparkinson agents - administration & dosage (1261) 1261
motor fluctuations (1240) 1240
dyskinesia (1222) 1222
levodopa - metabolism (1207) 1207
psychiatry (1182) 1182
mice (1130) 1130
aged, 80 and over (1097) 1097
parkinson disease - therapy (1051) 1051
double-blind (1033) 1033
analysis (991) 991
brain (973) 973
carbidopa - therapeutic use (942) 942
disease models, animal (938) 938
parkinson disease - diagnosis (921) 921
disease (915) 915
motor activity - drug effects (901) 901
parkinson’s disease (888) 888
parkinson disease - metabolism (885) 885
severity of illness index (883) 883
parkinson disease (872) 872
drug combinations (862) 862
neurodegenerative diseases (860) 860
rats, sprague-dawley (856) 856
double-blind method (851) 851
therapy (840) 840
antiparkinson agents - pharmacology (832) 832
dopamine agonists - therapeutic use (832) 832
corpus striatum - metabolism (801) 801
deep brain stimulation (796) 796
neurons (794) 794
subthalamic nucleus (785) 785
corpus striatum - drug effects (747) 747
levodopa-induced dyskinesia (746) 746
brain - metabolism (737) 737
levodopa-induced dyskinesias (732) 732
phenols (707) 707
parkinson disease - psychology (705) 705
dopamine agents - therapeutic use (686) 686
levodopa - pharmacokinetics (682) 682
follow-up studies (680) 680
biochemistry & molecular biology (657) 657
dyskinesia, drug-induced - etiology (637) 637
research (636) 636
dopamine agents - pharmacology (628) 628
adolescent (624) 624
drug therapy (604) 604
carbidopa - administration & dosage (601) 601
striatum (597) 597
brain - drug effects (593) 593
pharmacokinetics (580) 580
surgery (580) 580
care and treatment (577) 577
parkinsonian disorders - drug therapy (577) 577
dopamine - physiology (573) 573
diagnosis (565) 565
carbidopa (558) 558
drug administration schedule (557) 557
parkinsonism (553) 553
substantia-nigra (530) 530
medicine, general & internal (525) 525
parkinson disease - pathology (524) 524
rats, wistar (520) 520
analysis of variance (518) 518
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20092) 20092
German (506) 506
French (417) 417
Russian (400) 400
Spanish (365) 365
Japanese (356) 356
Italian (160) 160
Polish (98) 98
Chinese (75) 75
Portuguese (55) 55
Hungarian (34) 34
Dutch (29) 29
Czech (20) 20
Swedish (14) 14
Norwegian (13) 13
Danish (12) 12
Finnish (12) 12
Serbian (12) 12
Hebrew (10) 10
Slovak (10) 10
Korean (9) 9
Turkish (7) 7
Romanian (6) 6
Bulgarian (4) 4
Slovenian (3) 3
Ukrainian (3) 3
Croatian (2) 2
Persian (2) 2
Bosnian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Movement Disorders, ISSN 0885-3185, 04/2016, Volume 31, Issue 4, pp. 530 - 537
Journal Article
AAPS Journal, ISSN 1550-7416, 04/2013, Volume 15, Issue 2, pp. 316 - 323
Motor complications of Parkinson's disease (PD) are a consequence of pulsatile dopaminergic stimulation from standard oral levodopa therapy. Levodopa-carbidopa... 
Duodopa | Levodopa-carbidopa intestinal gel | Parkinson's disease | Pharmacokinetics | LCIG | ENTACAPONE | CONTINUOUS DOPAMINERGIC STIMULATION | ORAL LEVODOPA | LEVODOPA/CARBIDOPA | RELEASE | TRANSPORT | THERAPY | FLUCTUATIONS | L-DOPA | PHARMACOLOGY & PHARMACY | ABSORPTION | Humans | Middle Aged | Intubation, Gastrointestinal - instrumentation | Levodopa - pharmacokinetics | Male | Tyrosine - blood | Parkinson Disease - drug therapy | Tyrosine - analogs & derivatives | Intestinal Absorption | Jejunum - metabolism | Levodopa - chemistry | Sweden | Levodopa - administration & dosage | Biotransformation | Carbidopa - adverse effects | Antiparkinson Agents - chemistry | Female | Tyrosine - pharmacokinetics | Carbidopa - blood | Carbidopa - administration & dosage | Gels | Infusion Pumps | Carbidopa - pharmacokinetics | Carbidopa - chemistry | Antiparkinson Agents - adverse effects | Levodopa - blood | Chemistry, Pharmaceutical | Antiparkinson Agents - pharmacokinetics | Antiparkinson Agents - blood | Levodopa - adverse effects | Parkinson Disease - diagnosis | Aged | Antiparkinson Agents - administration & dosage | Parkinson Disease - blood | Drug Combinations | Germany | Complications and side effects | Neurosciences | Carbidopa | Metabolites | Universities and colleges | Dopa | Oral medication | Index Medicus | Clinical Medicine | Neurology | Neurologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 03/2017, Volume 83, Issue 3, pp. 540 - 553
Journal Article
Journal Article
CLINICAL INTERVENTIONS IN AGING, ISSN 1176-9092, 2010, Volume 5, pp. 229 - 238
After more than 40 years of clinical use, levodopa (LD) remains the gold standard of symptomatic efficacy in the drug treatment of Parkinson's disease (PD).... 
Parkinson's disease | levodopa | motor fluctuations | dyskinesia | GERIATRICS & GERONTOLOGY | Dyskinesia, Drug-Induced - etiology | Levodopa - administration & dosage | Humans | Levodopa - adverse effects | Aged | Antiparkinson Agents - administration & dosage | Parkinson Disease - drug therapy | Antiparkinson Agents - adverse effects
Journal Article
European Journal of Neurology, ISSN 1351-5101, 02/2014, Volume 21, Issue 2, pp. 312 - 318
Journal Article
Neurology, ISSN 0028-3878, 03/2019, Volume 92, Issue 10, pp. 453 - 454
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established treatment for advanced Parkinson disease (PD) with severe motor... 
CLINICAL NEUROLOGY | LEVODOPA
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 829 - 836
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned non-human primate is widely used to model Parkinson's disease (PD) and to evaluate the... 
l-DOPA | Parkinson's disease | Pharmacokinetics | MPTP-lesioned macaque | Dyskinesia | ANTAGONIST | LEVODOPA-INDUCED DYSKINESIAS | PHARMACODYNAMICS | CEREBROSPINAL-FLUID | NEUROSCIENCES | CARBIDOPA | MICRODIALYSIS | ANTIPARKINSONIAN ACTION | PLASMA | FLUCTUATIONS | L-DOPA | PHARMACOLOGY & PHARMACY | MONKEYS | Parkinsonian Disorders - cerebrospinal fluid | Basal Ganglia - metabolism | Half-Life | Levodopa - pharmacokinetics | Macaca fascicularis | Antiparkinson Agents - cerebrospinal fluid | Biological Availability | Metabolic Clearance Rate | Dyskinesia, Drug-Induced - prevention & control | Chromatography, High Pressure Liquid | Parkinsonian Disorders - metabolism | Tissue Distribution | Dopamine Agents - blood | Tandem Mass Spectrometry | Spectrometry, Mass, Electrospray Ionization | Levodopa - administration & dosage | Parkinsonian Disorders - drug therapy | Dopamine Agents - pharmacokinetics | Behavior, Animal - drug effects | Female | Levodopa - cerebrospinal fluid | Dyskinesia, Drug-Induced - etiology | Severity of Illness Index | Benserazide - administration & dosage | Parkinsonian Disorders - physiopathology | Levodopa - blood | Caudate Nucleus - metabolism | Dopamine Agents - metabolism | Antiparkinson Agents - pharmacokinetics | Animals | Antiparkinson Agents - blood | Dopamine Agents - cerebrospinal fluid | Antiparkinson Agents - metabolism | Levodopa - metabolism | Drug Combinations | Primates | Phenols | Monkeys | Analysis | Index Medicus | Drugs | Brain | Animal models | Basal ganglia | Neurodegenerative diseases | Central nervous system diseases | Mass spectroscopy | Bioavailability | Cerebrospinal fluid | Caudate nucleus | Levodopa | MPTP | Movement disorders
Journal Article
Movement Disorders, ISSN 0885-3185, 05/2015, Volume 30, Issue 6, pp. 788 - 795
Journal Article